Fortuna Fix

Fortuna Fix is a private clinical-stage biotechnology company with a patented direct cell reprogramming technology platform (drNPC) and proprietary bio-scaffold technology (RMx™), used for treating neurodegenerative diseases and neurological trauma. The company focuses on its leading projects in spinal cord injury and Parkinson's disease, while further advancing in stroke, traumatic brain injury, hearing loss, and ALS. It has developed a proprietary, large-scale, fully automated GMP production system for manufacturing autologous drNPC.